SCHEMBL3515734

SCHEMBL3515734

O=c1c(-c2ccccc2)c(O)c2cc(S(=O)(=O)NCc3ccccc3)cnc2n1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 4/20 0.46
TSHR P16473 1/20 0.44
KMT2A Q03164 1/20 0.44
BRD4 O60885 1/20 0.43
KEAP1 Q14145 1/20 0.41
PIK3C3 Q8NEB9 1/20 0.40
KDM4E B2RXH2 1/20 0.40
PIK3CG P48736 3/20 0.39
PIK3CD O00329 2/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
PDK1 Q15118 1/20 0.39
MCL1 Q07820 1/20 0.39
ALDH1A1 P00352 1/20 0.39
PKM P14618 1/20 0.39
LMNA P02545 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CA12 O43570 1/20 0.38
CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3517752 0.84 UQCRB (0.39) KMT2AKEAP1PIK3C3KDM4EHDAC2
SCHEMBL3517390 0.78 KDM4E (0.41) KMT2AKDM4EMCL1ALDH1A1LMNA
SCHEMBL3525616 0.76 KMT2A (0.43) KMT2AKDM4EMCL1ALDH1A1LMNA
SCHEMBL3518351 0.76 KDM4E (0.47) KMT2AKDM4EMCL1ALDH1A1LMNA
SCHEMBL13435228 0.74 KDM4E (0.47) KMT2AKDM4EMCL1ALDH1A1LMNA
SCHEMBL3515715 0.74 KMT2A (0.42) KMT2AKDM4EMCL1ALDH1A1LMNA
SCHEMBL3517548 0.74 KMT2A (0.44) TSHRKMT2AKDM4EMCL1ALDH1A1
SCHEMBL3518153 0.74 AR (0.39) POLBKMT2APKM
SCHEMBL3515126 0.74 AVPR1B (0.40) KMT2AKDM4EMCL1LMNASMN1; SMN2
SCHEMBL3519936 0.74 IP6K1 (0.41) POLBKMT2AKDM4EMCL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100056516-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS MERCK SHARP & DOHME CORP. 2010-03-04 US disclosed
US-20100056516-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS MERCK SHARP & DOHME CORP. 2010-03-04 US disclosed
US-20100056516-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS MERCK SHARP & DOHME CORP. 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056516-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS RNASEH1, RNASE1, RNASEL POLB 25/4885TSHR 3624/4885KMT2A 2764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.